In this month’s business report, we take a look at some of the key trends in drug delivery deal making across the past five years, including the types of deal being signed, the indication areas involved and the changes in overall deal value. We also discuss some of the key issues in drug delivery commercialisation and review the industry drivers behind the promising growth in this sector of the pharmaceutical and biotech industry.